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Cytokine-based Predictive Models 
to Estimate the Probability of 
Chronic Periodontitis: Development 
of Diagnostic Nomograms
I. Tomás1, N. Arias-Bujanda1, M. Alonso-Sampedro2, M. A. Casares-de-Cal3, C. Sánchez-
Sellero3, D. Suárez-Quintanilla1 & C. Balsa-Castro1
Although a distinct cytokine profile has been described in the gingival crevicular fluid (GCF) of patients 
with chronic periodontitis, there is no evidence of GCF cytokine-based predictive models being used 
to diagnose the disease. Our objectives were: to obtain GCF cytokine-based predictive models; and 
develop nomograms derived from them. A sample of 150 participants was recruited: 75 periodontally 
healthy controls and 75 subjects affected by chronic periodontitis. Sixteen mediators were measured 
in GCF using the Luminex 100™ instrument: GMCSF, IFNgamma, IL1alpha, IL1beta, IL2, IL3, IL4, 
IL5, IL6, IL10, IL12p40, IL12p70, IL13, IL17A, IL17F and TNFalpha. Cytokine-based models were 
obtained using multivariate binary logistic regression. Models were selected for their ability to predict 
chronic periodontitis, considering the different role of the cytokines involved in the inflammatory 
process. The outstanding predictive accuracy of the resulting smoking-adjusted models showed that 
IL1alpha, IL1beta and IL17A in GCF are very good biomarkers for distinguishing patients with chronic 
periodontitis from periodontally healthy individuals. The predictive ability of these pro-inflammatory 
cytokines was increased by incorporating IFN gamma and IL10. The nomograms revealed the amount 
of periodontitis-associated imbalances between these cytokines with pro-inflammatory and anti-
inflammatory effects in terms of a particular probability of having chronic periodontitis.
Periodontal diseases are among the most common conditions affecting humans1. In 2010, severe periodontitis 
was estimated to be the sixth most prevalent disease globally, affecting 743 million people worldwide and with an 
age-standardized incidence of 701 cases per 100,000 person-years2.
A recent prevalence study of adult periodontitis in the USA, with data from the 2009 and 2010 National 
Health and Nutrition Examination Survey, revealed that over 47% of individuals had periodontitis, which equates 
to 64.7 million adults3, 4. During the recent 11th European Workshop on Periodontology, experts confirmed that 
the prevalence of periodontitis in Europe remains high, affecting more than 50% of the adult population and, in 
its severe forms, 11% of adults5. Periodontitis is not a “silent” problem: periodontal patients have a poorer percep-
tion of their oral health and a worse quality of life compared to healthy individuals, with periodontal treatment 
improving the oral health-related quality of life of these people6, 7.
On the other hand, periodontitis is currently being connected bidirectionally to the pathogenesis of various 
systemic diseases and conditions such as diabetes8; coronary heart disease9; rheumatoid arthritis10; respiratory 
diseases11; pre-term low birth weights12; and dementia13.
Traditional clinical measures are informative for evaluating the severity of periodontitis and the response to 
therapy, and these include: the presence or the level of bacterial plaque; gingival inflammation and bleeding upon 
probing; pocket depth and suppuration; the clinical attachment level; and radiographic bone loss14. Nevertheless, 
these clinical criteria are unable to determine current disease activity or the future risk of structure loss15, 16. As 
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a result, one of the major challenges in the field of Periodontology is to determine biomarkers for screening and 
predicting the early onset of periodontitis or evaluating the disease activity as well as the efficacy of therapy (diag-
nostic or prognostic tests)15, 17.
The primary hallmark of periodontitis, namely the destruction of periodontal tissue, is widely accepted to 
be a result of a chronic inflammatory host immune response caused by a polymicrobial dysbiosis18, 19. This host 
immune response is characterized by: 1) infiltration of the gingival tissues by neutrophils, monocytes/mac-
rophages and lymphocytes; and 2) the generation of high concentrations of mediators, including cytokines, 
chemokines, arachidonic acid metabolites and proteolytic enzymes18, 20. The nature and extent of this host 
immune response are fundamental determinants of the susceptibility to and progression of periodontitis21.
Gingival crevicular fluid (GCF) is an exudate of the serum originating from the gingival plexus of blood ves-
sels in the gingival connective tissue, close to the epithelium lining of the dentogingival space. With an increase in 
the severity of periodontal inflammation, the amount of GCF increases significantly. Additionally, its consistency 
transforms into an inflammatory exudate as it traverses the inflamed tissues, collecting bacterial and host mole-
cules22, 23. The collection of GCF is relatively non-invasive, and this sampling method has been shown to capture 
inflammatory and connective tissue breakdown mediators accurately23.
With the establishment of enzyme-linked immunosorbent assay (ELISA) techniques, interleukin (IL) 1beta 
was the first cytokine to be specifically measured in the gingival tissue of patients with chronic periodontitis24. 
Numerous papers since then have reported the measurement of cytokines in GCF, confirming that there is a 
distinct cytokine profile for patients with chronic periodontitis17, 25. The results concerning which cytokines are 
most involved in chronic periodontitis are, however, generally contradictory, due to the lack of uniformity in the 
methodological design of the studies25.
On the other hand, very few authors have examined the simultaneous presence of more than 10 cytokines 
in GCF, and there is a failure to analyse a broader spectrum of biomarkers that may directly influence the local 
inflammatory response in periodontitis26–28. Moreover, there is no evidence in the literature of the development, 
validation, or updating of GCF cytokine-based predictive models for diagnosing periodontitis or its prognosis 
using appropriate multivariate predictive modeling techniques29. As a consequence, it is quite clear that highly 
specific and sensitive biomarkers for monitoring periodontitis are still needed for the early and better detection 
of periodontal tissue destruction17.
Accordingly, the objectives of the present cross-sectional study were to:
 1) Compare the levels of 16 cytokines detected in GCF between periodontally healthy individuals and pa-
tients with chronic periodontitis.
 2) Obtain GCF cytokine-based predictive models that could be used to distinguish periodontal patients from 
periodontally healthy individuals.
 3) Develop nomograms derived from GCF cytokine-based predictive models.
Material and Methods
Selection of study groups. A convenience sample of 150 eligible participants, comprising 75 periodontally 
healthy controls (control group) and 75 subjects affected by moderate to severe generalized chronic periodontitis 
(perio group), were recruited among 250 consecutive patients of the general population who were referred to the 
School of Medicine and Dentistry (Universidade de Santiago de Compostela, Spain) for an assessment of their 
oral health status between 2013–2015. Patients were selected if they fulfilled the following inclusion criteria: 1) 
age 30 to 75; 2) no medical history of diabetes mellitus or hepatic or renal disease, or other serious medical con-
ditions or transmittable diseases; 3) no history of alcohol or drug abuse; 4) no pregnancy or breastfeeding; 5) no 
intake of systemic antimicrobials during the previous six months; 6) no intake of anti-inflammatory medication 
in the previous four months; 7) no routine use of oral antiseptics; 8) no presence of implants or orthodontic appli-
ances; 9) no previous periodontal treatment; 10) smokers, who had stopped smoking less than five years before 
the sampling; and 11) the presence of at least 18 natural teeth (Fig. 1).
One experienced dentist, who previously underwent a calibration exercise of the clinical parameters in a 
small group of patients, performed all the periodontal diagnoses. The probing pocket depth (PPD) and clinical 
attachment level (CAL) were recorded throughout the mouth on six sites per tooth using a PCP-UNC 15 probe. 
Bleeding on probing (BOP) and bacterial plaque level (BPL) were recorded for the full mouth on a binary scale 
(presence/absence) on six sites per tooth (BOP and BPL, respectively). Standardized radiographs of all teeth were 
obtained to assess the alveolar bone status.
The presence or absence of chronic periodontitis was based on clinical/radiographic information. The control 
group included periodontally healthy individuals with BOP < 25%, no sites with a PPD ≥ 4 mm and no radio-
graphic evidence of alveolar bone loss. The perio group patients were diagnosed as suffering from moderate to 
severe generalized chronic periodontitis based on the previously established criteria30, 31. Smoking histories were 
obtained using a questionnaire, with information collected on smoking status (never, past or current), the years 
(months) of smoking and the number of cigarettes/day. All answers were reviewed with the subject by a member 
of the study team.
This study was conducted according to the principles outlined in the Declaration of Helsinki (as revised in 
2000) on experimentation involving humans32. The transparent reporting of a multivariable prediction model for 
individual prognosis or diagnosis (TRIPOD) guidelines were considered29.
Gingival crevicular fluid sampling. The GCF collection took place one week after the initial examination, 
and the samples were obtained at the same time of day (in the afternoon, approximately 5–7 h after toothbrush-
ing). Prior to the sampling, the individual tooth site was isolated with cotton rolls, supragingival plaque was 
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carefully removed and the site was gently air-dried with an air syringe. A paper strip (Periopaper, Amityville, NY, 
USA) was inserted into the gingival sulcus or periodontal pocket for 30 sec. In cases of visible contamination with 
blood, the strips were discarded and new sites sampled.
GCF samples from the periodontally healthy patients were collected and pooled from 20 sites from teeth 
in quadrants 1 and 3 (incisor, canine, first premolar, second premolar and molar). In the periodontal patients, 
subgingival samples were collected and pooled from the deepest PPD sites in each quadrant (a total of 20 
non-adjacent proximal sites). Strips from each subject were placed into labelled tubes containing: 300 ml of 0.01M 
PBS with a pH of 7.2; and a protease inhibitor (Complete Mini, protease inhibitor cocktail tablets, Roche Applied 
Science, Indianapolis, IN, USA). To prevent evaporative losses, the GCF volume was determined based on imme-
diate measurements of weighing the tubes and strips before and after the sample collection using a very sensitive 
scale22.
After shaking for 20 min, the strips were removed and the eluates centrifuged for 5 min at 5800 g to remove 
plaque and cellular elements. The GCF samples were then frozen at −80 °C until further biochemical analysis.
Quantification of cytokines in gingival crevicular fluid using multiplexed bead immuno-
assays. A single investigator blinded to the clinical data performed the quantitative cytokine analy-
ses. Cytokine levels in the GCF were determined using the human cytokine 16-plex Procarta immunoassay 
(Affymetrix, Inc., Santa Clara, CA, USA). Sixteen mediators were measured: 1) eight pro-inflammatory cytokines 
(granulocyte-macrophage colony stimulating factor – GMCSF -, IL1alpha, IL1beta, IL6, IL12p40, IL17A, IL17F 
and TNFalpha); and 2) eight anti-inflammatory cytokines (IFNgamma, IL2, IL3, IL4, IL5, IL10, IL12p70 and 
IL13).
The assays were performed in 96-well filter plates following the manufacturer’s instructions. Briefly, the filter 
plates were pre-wet with washing buffer and the solution was aspirated from the wells using a handheld magnetic 
separator block (Millipore Corporation, Billerica, MA). Microsphere beads coated with monoclonal antibodies 
to the 16 different target analytes were added to the wells. Standards and samples were pipetted into the wells 
and incubated overnight at 4 °C. The wells were then washed, again using a handheld magnetic separator block 
(Millipore Corporation), and a mixture of biotinylated secondary antibodies was added.
After incubation for 30 min, streptavidin conjugated to the fluorescent protein R-phycoerythrin 
(streptavidin-RPE) was added to the beads and incubated for 30 min. After washing to remove the unbound 
reagents, a reading buffer (Affymetrix, Inc) was added to the wells and the beads (minimum of 100 per analyte) 
were analysed using the Luminex 100™ instrument (Luminex Corporation, Austin, Texas, USA). All the samples 
were run in duplicate.
The Luminex 100™ monitored the spectral properties of the beads to distinguish the different analytes while 
simultaneously measuring the amount of fluorescence associated with R-phycoerythrin, which is reported as the 
median fluorescence intensity (MFI). The concentrations of the unknown samples (antigens in the GCF samples) 
were: 1) estimated from the standard curve using a 5PL algorithm and the Luminex IS 2.3 and xPONENT 3.1 
softwares (Luminex Software, Inc.); and 2) expressed as pg/ml adjusting for the dilution factor. The concentration 
Figure 1. Selection of study groups.
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ranges for each biomarker analysed were: GMCSF, 0.53–55,050 pg/ml; IFNgamma, 0.02–6,650 pg/ml; IL1alpha, 
0.34–28,800 pg/ml; IL1beta, 0.09–23,150 pg/ml; IL2, 0.04–13,700 pg/ml; IL3, 0.19–26,500 pg/ml; IL4, 0.10–
29,250 pg/ml; IL5, 0.04–17,800 pg/ml; IL6, 0.10–27,200 pg/ml; IL10, 0.04–10,050 pg/ml; IL12p40, 0.14–27,350 pg/
ml; IL12p70, 0.26–18,050 pg/ml; IL13, 0.34–23,700 pg/ml; IL17A, 0.36–30,900 pg/ml; IL17F, 0.25–34,700 pg/ml; 
and TNFalpha, 0.21–16,800 pg/ml.
Samples below the detection limit (DL) of the assay were recorded as DL/233, while samples above the upper 
limit of quantification of the standard curves were assigned the highest value of the curve.
Statistical analysis. The statistical analyses were performed using the R software34. A supplementary file 
shows the data frame used in the present study for comparative and predictive analysis (Supplementary Dataset 1).
Comparison of clinical characteristics between control individuals and patients with chronic periodontitis. 
Univariate tests to detect differences in the clinical characteristics between the control and perio groups were 
performed. The normality assumption of the quantitative variables was checked by the Shapiro-Wilk test, with 
the result being that the normality hypothesis was not valid in all the cases. Consequently, the Mann-Whitney U 
test was used to compare the quantitative clinical characteristics between both groups (age, number of teeth and 
the clinical parameters BPL, BOP and CAL in the full mouth and the sampled sites). The Fisher’s exact test was 
used to assess the association between the qualitative variables (gender and smoking habit) between both study 
groups. The significance level applied was p < 0.05.
Comparison of GCF cytokine levels between control individuals and patients with chronic periodontitis. After 
applying the Shapiro-Wilk test, and because the distributions of the cytokines were skewed, we used logarith-
mically transformed values (log2) for the statistical analyses. Histograms were made for each variable before and 
after the logarithmic transformation, showing how the transformation produces a less skewed and more suitable 
distribution for further analysis.
Quantitative data on the GCF cytokine levels were expressed as medians and interquartile ranges. The 
Mann-Whitney U test was used to compare the GCF cytokine levels between control group and perio group.
Multivariate predictive modeling of chronic periodontitis based on GCF cytokine levels: model selection and valida-
tion, and the development of nomograms. Spearman correlations between cytokines were calculated and used as 
an orientation for model building, in order to prevent redundancies and possible collinearity between cytokines 
with similar biological effects. Cytokine-based models were selected for their biological significance, their capac-
ity to predict chronic periodontitis and their statistical validity. The biological criteria to select the predictor 
cytokines are based on their importance level in the inflammatory process, and particularly the different role of 
pro-inflammatory and anti-inflammatory cytokines.
Models were constructed by initially selecting one pro-inflammatory cytokine as predictor variable. In 
order to test whether the predictive ability of pro-inflammatory cytokines can be increased by incorporating 
cytokines with anti-inflammatory effects, two-variable models combining these different mediators were ana-
lysed. Resulting models were adjusted individually in relation to the “smoking status” (a non-smoking status was 
established as the reference).
The statistical criterion applied for model selection was the capacity of each GCF cytokine-based model to 
discriminate the presence of chronic periodontitis, that was assessed with the Epi package and using the receiver 
operating characteristic (ROC) curve35. This curve was created by plotting the true positive rate (TPR; sensitivity) 
versus the false positive rate (FPR; 1-specificity) at various threshold settings of the analyses. The area under the 
curve (AUC), which is the C index, was regarded as a measure for the discriminative capacity of the model and 
provides a scale from 0.5 to 1.0 (with 0.5 representing random chance and 1.0 indicating perfect discrimination) 
with which to compare the ability of a biomarker to detect a positive result36. Note that models with an AUC value 
equal to or higher than 0.70 are typically considered to be acceptable predictive models37. The calculation of the 
AUC values and their corresponding 95% CIs by bootstrapping were performed using the pROC package38. Those 
models that presented higher AUC values were selected.
Of the selected cytokine-based models, using the pROC package and bootstrapping, numerous classification 
measures such as accuracy (ACC), sensitivity, specificity, the positive predictive value (PPV), and the negative 
predictive value (NPV) were obtained by setting an optimal threshold, as well as their corresponding 95% CIs38. 
The best cut-off value for each model was determined so that the percentage of correct predictions was the max-
imum. As a single indicator of diagnostic performance, the diagnostic odds ratio (DOR) was calculated as the 
ratio of the odds of positivity in the diseased patients relative to the odds of positivity in those with no disease39.
The Hosmer–Lemeshow test was applied to the selected cytokine-based models, using the Resource Selection 
package40. This is a calibration measure, which is significant for poorly calibrated models41. Calibration curves of 
these models were constructed graphically using the rms package42 to assess the agreement between the actual 
outcomes and the predicted probabilities of chronic periodontitis. In a well-calibrated model, the predictions 
should fall on a 45-degree diagonal line41.
The nomograms were built based on the results of multivariable analyses using the rms package42. A nomo-
gram maps the predicted probabilities into points on a scale from 0 to 100 in a user-friendly graphical interface. 
The total points accumulated by the various covariates correspond to the predicted probability of disease for a 
patient43.
Internal validation. Bootstrap methods were used to test for possible overfitting by determining optimism val-
ues on the discrimination, classification and calibration measures. The bootstrap analysis was replicated on 1000 
different samples of the same sample size drawn with replacements from the original sample. Optimism, which 
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is a measurement of internal model validation that refers to the absolute magnitude of bias, equals the difference 
between respective statistics of the bootstrap sample (bootstrap performance) and the bootstrap model in the 
original sample (test performance)44, 45.
Bias-corrected (bc) AUC, all the classification measures (bc-sensitivity, bc-specificity, bc-PPV, bc-NPV), 
bc-calibration measures were calculated as their corresponding apparent measures derived from the entire 
original sample minus optimism44, 45. In terms of the bc-DOR, these ratios were calculated from the values of 
bc-sensitivity and bc-specificity. Figure 2 shows the flow chart of statistical analysis: binary logistic regression and 
diagnostic nomograms.
Declarations. Ethics approval and consent to participate. The study’s protocol was approved by the Clinical 
Research Ethics Committee of Galicia (number 2015/006). Patients who agreed to participate in the research 
provided written informed consent.
Consent for publication. Not applicable.
Availability of data and material. All data generated or analysed during this study are included in this published 
article (and its supplementary information files).
Results
Comparison of clinical characteristics between control individuals and patients with chronic 
periodontitis. Of the 150 patients, who had fulfilled the inclusion criteria and an adequate periodontal diag-
nosis, 3 patients were excluded for unexpected events (Fig. 1). Of the 147 patients taking part in the study, who 
had a mean age of 48.37 ± 11.55 years, 62 were male and 85 female. The mean ages of patients of control and 
perio groups were 45.65 ± 12.37 and 51.12 ± 10.01 years, respectively (p = 0.005). In relation to smoking status, 
the number of smoker patients was significantly higher in the perio group than in the control group (41 and 13 
patients, respectively; p < 0.001). The analysis of clinical variables related to oral health status showed that, in 
comparison with the control group, the perio group had significantly higher values of BPL, BOP, PPD and CAL at 
both the full mouth and sampling site levels (p < 0.001; Table 1).
Comparison of GCF cytokine levels between control individuals and patients with chronic per-
iodontitis. Before the logarithmic transformation, the raw variables were very skewed, which makes difficult 
Figure 2. Flow chart of statistical analysis: binary logistic regression and diagnostic nomograms.
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to distinguish between individuals with small to moderate cytokine levels. After the logarithmic transformation, 
the individuals were more regularly spread in the possible values of the transformed variables. Histograms of each 
cytokine before and after the logarithmic transformation are given in Supplementary Figs S1–16.
The levels of all the pro-inflammatory cytokines (GMCSF, IL1alpha, IL1beta, IL6, IL12p40, IL17A, IL17F 
and TNFalpha) were significantly higher in the perio group compared to the control group (p < 0.001, for all 
comparisons). Regarding the anti-inflammatory cytokines, only four mediators (IFNgamma, IL2, IL3 and IL4) 
presented significantly higher concentrations in the perio group (p < 0.001, for all comparisons). The increase in 
the concentrations of these anti-inflammatory cytokines was lower than that detected for the pro-inflammatory 
cytokines, except for IL3 (Table 2). Boxplots for each cytokine in both study groups are given in Supplementary 
Figs S17–33.
Multivariate predictive modeling of chronic periodontitis based on GCF cytokine levels: model 
selection and validation, and the development of nomograms. For multivariate predictive analy-
sis, we had a total of 147 participants and 73 outcome events. A first description of the relation between cytokine 
levels is given in Supplementary Dataset 2, by means of their Spearman correlations. Almost all correlations 
between cytokines, both pro-inflammatory and anti-inflammatory, were positive. The interpretation is that 
when periodontitis-associated inflammation was present, all cytokines presented larger values. Additionally, we 
observed larger correlations between pro-inflammatory cytokines. Particularly, strong positive correlations were 
detected between some very relevant pro-inflammatory cytokines, IL1alpha, IL1beta and IL17A (rho > 0.85). 
Note also that in the given boxplots these cytokines showed the biggest differences between both study groups.
Respect to the one-cytokine models adjusted by “smoking”, the pro-inflammatory cytokines IL1alpha, IL1beta 
and IL17 were the predictors that showed higher AUC values (0.973, 0.963, 0.937, respectively). Regarding the 
two-cytokine models adjusted by “smoking”, the incorporation of certain anti-inflammatory cytokines improved 
the AUC values of the best models based on a pro-inflammatory cytokine, especially that of IL17A (from 0.937 to 
0.974). These two-cytokine models were: IL1alpha + IFNgamma, IL1beta + IL10 and IL17A + IFNgamma. The 
description of these six models, as well as their corresponding discrimination measures, are detailed in Table 3.
The IL1beta model presented the highest bc-ACC percentage (93.0%; bc-sensitivity = 92.1%; 
bc-specificity = 93.9%; bc-DOR = 183.0), followed by the IL1alpha (91.5%; bc-sensitivity = 92.7%; 
bc-specificity = 90.4%; bc-DOR = 120.7), and IL17A (88.0%; bc-sensitivity = 88.2%; bc-specificity = 87.9%; 
bc-DOR = 55.0).
In relation to two-cytokine models, the IL1alpha + IFNgamma model and IL1beta + IL10 model showed 
similar bc-ACC percentages (93.7% and 93.5%; bc-sensitivity = 91.7% and 93.3%; bc-specificity = 95.7% and 
93.8%); while the IL17A + IFNgamma model had lower values of bc-ACC (91.2%; bc-sensitivity = 89.1%; 






(n= 73) P Value
Age (years) 45.65 (12.37) 51.12 (10.01) 0.005
Gender
  Male 31 31 NS
  Female 43 42
Smoking habit1
  Non-smokers 61 32 <0.001
  Smokers 13 41
    Cigarretes/day (no.) 8.08 (4.44) 15.20 (7.94) 0.001
    Months of smoking 
(no.) 236.38 (155.91) 320.78 (109.03) NS
No. of teeth 26.72 (3.25) 25.55 (4.00) NS
Full mouth
  BPL (%) 26.41 (18.66) 53.08 (26.77) <0.001
  BOP (%) 15.05 (6.61) 51.12 (20.07) <0.001
  PPD (mm) 2.11 (0.27) 3.49 (0.65) <0.001
  CAL (mm) 2.36 (0.46) 4.25 (1.12) <0.001
Sampled sites
  BOP (%) 10.11 (10.24) 66.97 (23.93) <0.001
  PPD (mm) 2.23 (0.22) 5.65 (0.89) <0.001
  CAL (mm) 2.31 (0.27) 6.05 (1.12) <0.001
Table 1. Age, gender, smoking habit and clinical characteristics associated with the periodontal status in the 
control and perio groups. Values are means (standard deviations) and number of subjects. BPL = bacterial 
plaque level; BOP = bleeding on probing; PPD = probing pocket depth; CAL = clinical attachment level; 
NS = not significant. 1-Patients were defined as smokers if he/she was currently smoking and had been a smoker 
for at least 8 years) and as non-smokers if he/she had never smoked or quitted smoking longer than 5 years 
before the sampling.
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Apparent and bias-corrected classification measures of the six cytokine-based models are described in Table 4. 
Additional information on these models and their corresponding performance measures are shown in 
Supplementary Dataset 3.
Figures 3 and 4 show the ROC curves and calibration plots, including the bias-corrected measures, of the six 
cytokine-based models. The smoking-adjusted models based on IL1alpha and IL17A + IFNgamma were the best 
calibrated graphically, showing these predictors a linear effect on the outcome. The IL1alpha model presented a 
bc-intercept of −0.022 and a bc-slope of 0.933, and the IL17A + IFNgamma model, −0.013 and 0.885, respec-
tively. The values of the Hosmer–Lemeshow test were non-significant (p = 0.504 and 0.522, respectively).
Figures 5 and 6 show the diagnostic nomograms derived from the six cytokine-based models. As has been 
commented upon previously, the discrimination and classification performance values of these nomograms 
were very high, indicating their outstanding accuracy. According to the calibration parameters, especially the 
nomogram based on the IL1alpha and IL17 + IFNgamma were very reliable, because these showed very good 
correspondence between the actual outcomes and the predicted probabilities of having chronic periodontitis. In 
general, in three nomograms of two cytokines, higher levels of pro-inflammatory cytokines were associated with 
an increased probability of having chronic periodontitis, as did being a smoker. On the contrary, IFNgamma and 
IL10 had an opposite function to the pro-inflammatory ones, as higher levels of these mediators were associated 
with a reduced probability of having periodontitis.
Discussion
The importance of cytokines in the pathogenesis of periodontal disease has been demonstrated in different stages. 
Not only do they act as initiators and regulators of the innate and adaptive immune response, but they also medi-
ate the tissue damage that leads to a loss of function and clinical disease14, 20, 46. Specifically, cytokines such as 
GMCSF, IL1beta, IL6, IL17 and TNFalpha are among the more important pro-inflammatory mediators when it 
comes to stimulating osteoclast activation17, 18. On the other hand, anti-inflammatory cytokines such as IL2, IL4, 
Cytokine
Concentration in CGF (log2 pg/ml) Median (IQR)
P ValueControl group Perio group
GMCSF 7.244 (1.214) 7.954 (1.485) <0.001
IL1alpha 14.931 (0.889) 17.183 (1.665) <0.001
IL1beta 11.500 (0.996) 14.132 (1.357) <0.001
IL6 7.285 (1.956) 8.296 (2.002) <0.001
IL12p40 3.120 (0.970) 4.173 (0.927) <0.001
IL17A 3.006 (2.029) 4.867 (1.277) <0.001
IL17F 2.046 (1.525) 3.373 (1.710) <0.001
TNFalpha 2.862 (1.697) 4.554 (0.979) <0.001
IFNgamma 2.417 (1.185) 3.363 (1.395) 0.001
IL2 3.424 (1.133) 3.973 (0.702) <0.001
IL3 5.607 (1.071) 6.649 (1.880) <0.001
IL4 2.745 (2.449) 3.713 (2.584) <0.001
IL5 3.219 (1.301) 3.625 (0.836) 0.495
IL10 2.640 (1.577) 3.101 (2.080) 0.087
IL12p70 3.174 (3.053) 3.864 (1.976) 0.352
IL13 4.904 (2.881) 5.066 (3.514) 0.458
Table 2. Comparison of concentrations of 16 cytokines between both study groups. IQR, interquartile range; 
CGF, crevicular gingival fluid. Concentration range for each biomarker analysed: GMCSF, 0.53–55,050 pg/ml; 
IFNgamma, 0.02–6,650 pg/ml; IL1alpha, 0.34–28,800 pg/ml; IL1beta, 0.09–23,150 pg/ml; IL2, 0.04–13,700 pg/
ml; IL3, 0.19–26,500 pg/ml; IL4, 0.10–29,250 pg/ml; IL5, 0.04–17,800 pg/ml; IL6, 0.10–27,200 pg/ml; IL10, 
0.04–10,050 pg/ml; IL12p40, 0.14–27,350 pg/ml; IL12p70, 0.26–18,050 pg/ml; IL13, 0.34–23,700 pg/ml; IL17A, 
0.36–30,900 pg/ml; IL17F, 0.25–34,700 pg/ml; TNFalpha, 0.21–16,800 pg/ml.
Cytokine-based Models AUC bc-AUC
−50.322 + 3.133IL1alpha + 1.783SmokingCurrent 0.973 0.971
−27.729 + 2.136IL1beta + 1.722SmokingCurrent 0.963 0.962
−7.607 + 1.823IL17A + 1.860SmokingCurrent 0.937 0.934
−71.383 + 4.622IL1alpha −1.146IFNgamma + 2.042SmokingCurrent 0.986 0.983
−28.811 + 2.331IL1beta −0.505IL10 + 1.701SmokingCurrent 0.971 0.967
−12.376 + 5.024IL17A −3.167IFNgamma + 2.984SmokingCurrent 0.974 0.971
Table 3. Description of the six smoking-adjusted models based on cytokine levels, including the apparent and 
bias-corrected AUC values.
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IL5, IL10 and IL13 play a major role in the regulation of T-cell subsets that act at a number of levels, with some of 
them having an inhibitory effect on osteoclastogenesis (IL13 and IFNgamma)17, 18.
Methodological issues of the published papers. Numerous papers published in the literature have 
reported the quantification of cytokines in GCF, confirming that there is a distinct cytokine profile for patients 
with chronic periodontitis17, 25. In a recently published meta-analysis study, however, Stadler et al.25 demonstrated 
that many of these studies were underpowered (using a small number of subjects and limited assays) and based 
on a classical reductionist approach because they were focused on just a few cytokines at a time. Although it is 
generally accepted that the immunopathogenesis of periodontitis is driven by complex and dynamic networks of 
cytokine interactions14, very few authors have evaluated the simultaneous presence of more than 10 cytokines in 
GCF26–28.
In the present study, we used a “knowledge-based” approach and included pro-inflammatory and 
anti-inflammatory cytokines to construct our panel of 16 biomarkers, selecting those with significant evidence 
of their role in the pathophysiology of chronic periodontitis. By selecting different classes of cytokines, we aimed 
to reduce the chances of redundancy among these mediators, potentially improving the diagnostic properties of 
the multi-cytokine models.
Unlike the position observed in numerous studies25, the pooled GCF sample collected from 20 subgingival 
sites of each patient allowed us to obtain a representative patient-level descriptor of the whole-mouth periodontal 
inflammatory response at certain times47. This can be related to a patient-level periodontitis status and possibly 
a patient-level disease risk. In the present study, we used a multiplex bead immunoassay for the simultaneous 
analysis of 16 cytokines in the GCF samples. Despite being a technique applied in less than 20% of the series25, 
these immunoassays provide a sensitivity that is equal to or better than the conventional enzyme-linked immu-
nosorbent assays and have the ability to measure multiple mediators simultaneously (up to 100 different analytes) 
in volumes as small as 50 µl or less. In contrast, such volumes would only be sufficient for the analysis of a single 
cytokine using the ELISA technique. Furthermore, the costs per analyte are relatively low and processing times 
are short48, 49. Like the ELISA or any other immunoassay, the sensitivity and specificity of multiplexed micro-
sphere assays depend on the use of high affinity, high specificity antibodies49.
The term ‘biomarker’ refers to a biologic compound, which can be quantified and analysed to serve as a bio-
logical indicator of physiological or pathogenic processes, environmental exposure and response to therapeutic 
interventions50. Oral fluids such as GCF and saliva, and even blood, have emerged as potential diagnostic tools 
for the detection of the biomarkers associated with periodontitis51–53. However, in terms of the cytokines in GFC, 
the majority of studies are simply designed to be cross-sectional, in which the cytokine levels in healthy vol-
unteers and periodontal patients are compared for testing, whether or not a particular mediator is increased/
decreased at the individual level20, 25. There is therefore no evidence in the literature on the development of GCF 
cytokine-based predictive models for the diagnosis or prognosis of periodontitis using appropriate multivariate 
predictive modeling techniques29. These techniques are useful tools with which to easily evaluate not just a single 
biomarker, but also a panel of biomarkers, which increases their diagnostic and prognostic power29. To the best of 
the authors’ knowledge, this is the first study in which diagnostic predictive models based on 16 cytokine levels in 
GCF have been evaluated and validated internally by multivariate predictive modeling techniques.
Comparison of GCF cytokine levels between control individuals and patients with chronic per-
iodontitis. In order to interpret the large amount of heterogeneous results published in the literature on 
the GCF cytokine levels in chronic periodontitis, Stadler et al.25 recently conducted a meta-analysis on the sub-











Value (%) Diagnostic OR
IL1alpha
93.1 94.5 91.8 92.1 94.5 195.5
91.5 92.7 90.4 90.5 92.9 120.7
Il1beta
93.8 93.1 94.5 94.5 93.4 238.0
93.0 92.1 93.9 93.8 92.4 183.0
IL17A
89.1 89.0 89.1 89.0 89.2 67.0
88.0 88.2 87.9 87.8 88.4 55.0
IL1alpha + IFNgamma
95.2 93.1 97.2 97.1 93.5 489.5
93.7 91.7 95.7 95.6 92.3 249.3
ILbeta + IL10
94.5 94.5 94.5 94.5 94.6 301.9
93.5 93.3 93.8 93.8 93.4 211.7
IL17A + IFNgamma
92.5 90.4 94.5 94.3 91.0 165.0
91.2 89.1 93.3 93.1 89.8 115.6
Table 4. Apparent and bias-corrected measures of discrimination and classification of the six smoking-adjusted 
models based on cytokine levels. In each cell, the first value is referred to the apparent performance measures 
and the second, to the corrected performance measures by the level of optimism calculated using a bootstrap 
procedure. The 95% CIs of the different performance measures, excepting diagnostic OR, are detailed in 
Supplementary Dataset 3.
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very few papers have focused on the role of anti-inflammatory cytokines (with IL4 and IL10 being the most 
researched)25. These authors found evidence of significant differences between chronic periodontitis and perio-
dontal health for only a few pro-inflammatory cytokines (IL1beta, IL6 and IL17, which showed higher levels for 
periodontitis than health). This first conclusion is corroborated by the results of the present study, although we 
also detected significantly elevated levels of other pro-inflammatory cytokines such as GMCSF, IL1alpha, IL12p40 
and TNFalpha. In our series, IL1alpha and IL1beta were the most important pro-inflammatory cytokines in terms 
of increased concentration associated with the disease, followed by IL6 and GMCSF, and IL17A and TNFalpha.
Equally, in the Stadler meta-analysis25, evidence of significant differences between chronic periodontitis and 
periodontal health was only found for a few anti-inflammatory cytokines (IFNgamma and IL4, which showed 
higher levels for health than periodontitis). Curiously, however, our results were contrary to those reported by 
these authors, as four anti-inflammatory cytokines (IFNgamma, IL2, IL3 and IL4) showed significantly higher 
concentrations in chronic periodontitis than in health. These increases were lower than those detected for the 
pro-inflammatory cytokines (with the exception of IL3). These discrepancies could be due to methodological 
differences detected in the studies in relation to the number of subgingival sites sampled and CGF levels obtained, 
which in many series could be insufficient to determine the levels of anti-inflammatory cytokines.
Multivariate predictive modeling of GCF cytokine levels: selection of the best models and 
the development of nomograms. In Periodontology, traditional clinical criteria are often inadequate 
for: 1) determining sites of active disease; 2) measuring the degree of susceptibility to future progression; or 
Figure 3. ROC curves and calibration plots of the one-cytokine models, including the apparent and bias-
corrected measures by bootstrapping. In the calibration plots, the predicted probability of the model is 
represented on the x-axis and the observed proportion of chronic periodontitis is represented on the y axis. The 
45° line indicates perfect congruity between the predicted probability and the observed proportion of chronic 
periodontitis.
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3) monitoring quantitatively the response to therapy. In this sense, there is a need for research on innovative 
diagnostic tests based on biomarkers that focus on the early recognition of the microbial challenge to the host, 
detecting real-time changes in the periodontium14, 16. On the other hand, the role of inflammation appears to be 
the common denominator between periodontitis and some of the systemic diseases and conditions mentioned 
in the Introduction to this paper. This emphasizes the importance of utilizing oral fluid diagnostic methods for 
monitoring periodontal diseases14. However, to date, limited research has been completed on the use of GCF as a 
diagnostic measure of periodontal disease54.
As an ideal diagnostic test should have predictive accuracy values approaching 100%17, in the present series, 
we surprisingly obtained a number of GCF cytokine-based models (six models) formed by one to two cytokines. 
These models were supported by the well-known biological role of the cytokines involved, had a capacity to dis-
criminate chronic periodontitis of >0.93 and were statistically validated models. Consequently, they were consid-
ered “outstanding predictive models”37, and demonstrated that cytokines could be very good biomarkers when it 
comes to distinguishing patients with chronic periodontitis from periodontally healthy individuals.
There are, however, contrary opinions defending the notion that cytokines are not specific enough for predict-
ing periodontitis, and their levels in the GCF may be affected by local or systemic factors such as smoking, alcohol 
consumption and stress15, 55. It has been stated that cytokine networks are complex, interactive, continuously 
changing, and have a redundant functionality, meaning that the interpretation of cytokine levels at one particular 
point in time is fraught with error56. In our opinion, however, these affirmations are questionable in the face of the 
strong evidence on predictive ability of certain cytokines found in the present study.
Figure 4. ROC curves and calibration plots of the two-cytokine models, including the apparent and bias-corrected 
measures by bootstrapping. In the calibration plots, the predicted probability of the model is represented on the 
x-axis and the observed proportion of chronic periodontitis is represented on the y axis. The 45° line indicates 
perfect congruity between the predicted probability and the observed proportion of chronic periodontitis.
www.nature.com/scientificreports/
1 1SCIENTIfIC REPORTS | 7: 11580  | DOI:10.1038/s41598-017-06674-2
Regarding the influence of other variables, smoking is a well-established traditional risk factor for chronic 
periodontitis57, 58, and its influence in the levels of some cytokines in the GCF from periodontal patients has been 
highlighted by previous authors27, 59. In the present series, we observed in the GCF cytokine-based models that 
smoking status increased by 15–20% the probability of having chronic periodontitis.
As there is no literature on the subject, our cytokine-based predictive models could not be compared to similar 
models, and we have had to consider predictive studies of periodontitis based on other biomarkers detected in the 
CGF56, 60. It is highly unlikely that a single biomarker can be a stand-alone measure for predicting periodontitis 
activity15, and several systemic conditions may affect the GCF levels of a single biomarker61.
In the present study, assuming the key role developed by pro-inflammatory cytokines in the pathogenesis of 
chronic periodontitis20, models were constructed by initially selecting one pro-inflammatory cytokine as pre-
dictor variable. Surprisingly, the smoking-adjusted models formed by IL1alpha, IL1beta and IL17A showed a 
high discriminative power (bc-AUC > 0.93), which resulted in corrected percentages of classification measures 
>87%. Of these pro-inflammatory cytokines, IL1beta was the one that presented the best predictive parameters 
(corrected classification measures >92%), followed by IL1alpha (corrected classification measures >90%) and 
IL17A (corrected classification measures >87%). It is very interesting to note the high predictive ability of IL17A, 
although this cytokine did not show an increase in levels associated with the disease especially high compared 
to that observed in other pro-inflammatory cytokines. These findings on the outstanding predictive accuracy of 
these pro-inflammatory cytokines in the CGF has not been previously described in the literature.
Figure 5. Nomograms based on the one-cytokine models predicting the probability of chronic periodontitis. 
The probability of chronic periodontitis is calculated by drawing a line to the point on the axis for each of the 
following variables: (a) IL1alpha and “smoking”; (b) IL1beta and “smoking”; (c) IL17A and “smoking”. The points 
for each variable are summed and located on the total point line. Next, a vertical line is projected from the total 
point line to the predicted probability bottom scale to obtain the individual probability of chronic periodontitis.
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However, a combined analysis of different valuable host-responses is required to identify the set of biomark-
ers with the most favourable combination of sensitivity, specificity and reproducibility15, 54. On the other hand, 
it is advisable to search for smaller multi-biomarker models, which are easier to apply in clinical practice than 
larger versions29, 62. In line with the GCF multi-biomarker predictive models for having peri-implantitis recently 
described by Zani et al.63, we analyzed the two-variable models that combined IL1alpha, IL1beta and IL17A with 
anti-inflammatory cytokines. The purpose was to test if the predictive capacity of these pro-inflammatory cytokines 
can be increased by the incorporation of cytokines with anti-inflammatory effects. Three smoking-adjusted 
models were found that fulfilled this premise: IL1alpha + IFNgamma, IL1beta + IL10 and IL17A + IFNgamma 
(bc-AUC > 0.96; corrected classification measures >89%). To the best of our knowledge, these results are 
the first evidence on the high predictive ability of models based on a pro-inflammatory cytokine and another 
anti-inflammatory to distinguish a patient with chronic periodontitis from one with periodontal health.
According to TRIPOD29, it was very interesting to test how, although IL10 alone showed non-significant high 
levels in chronic periodontitis, this acquired an important value within the two-biomarker model, increasing the 
discriminative capacity of the IL1beta. This corroborates, together with the finding previously commented on 
IL17A, the importance of designing future studies focused on predictive analysis that are properly powered. In 
these studies, a large number of periodontitis-related mediators should be evaluated using appropriate multivar-
iate statistical techniques20, 25.
Figure 6. Nomograms based on the two-cytokine models predicting the probability of chronic periodontitis. 
The probability of chronic periodontitis is calculated by drawing a line to the point on the axis for each of the 
following variables: (a) IL1alpha, IFNgamma and “smoking”; (b) IL1beta, IL10 and “smoking”; (c) IL17A, 
IFNgamma and “smoking”. The points for each variable are summed and located on the total point line. Next, 
a vertical line is projected from the total point line to the predicted probability bottom scale to obtain the 
individual probability of chronic periodontitis.
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In the present series, the best predictive models according to their bc-ACC values were formed by 
IL1alpha + IFNgamma (bc-AUC > 0.98, bc-ACC > 93% and other corrected classification measures >91%) and 
IL1beta + IL10 (bc-AUC > 0.96, bc-ACC > 93% and other corrected classification measures >93%), followed by 
IL17A + IFN gamma (bc-AUC > 0.97, bc-ACC > 91% and other corrected classification measures >89%). This 
accuracy in terms of predicting chronic periodontitis is much greater than that found in previous studies based 
on other biomarkers detected in CGF. As a consequence, the model recently validated by Kim et al.60, which 
consisted of matrix metalloproteinases (MMP-8, -9, and -13), had an AUC value of 0.84, with a sensitivity and 
specificity of 70% and 86%, respectively. When other demographic variables and risk factors (age, sex, income, 
smoking, drinking), as well as blood cytokine levels (IL6, IL8 and TNFalpha), were included in this model, the 
AUC value increased up to 0.86.
Nomograms are simplified representations of complicated statistical models, and their clinical value relates to 
the fact that they map the predicted probabilities into points on a scale from zero to 100 in a user-friendly graph-
ical interface43. To our knowledge, this is the first study providing several nomograms based on GCF cytokine 
levels to predict the probability of having chronic periodontitis.
The use of only a few variables is desirable in nomograms to increase their utility in clinical practice62. It has 
been suggested that the proper calibration of a nomogram is more clinically useful than its discriminatory capac-
ity64. Our nomograms, which are derived from the one- and two-cytokine models, fulfilled the requirements 
of discrimination. According to the calibration measures, especially the nomogram based on the IL1alpha and 
IL17A + IFNgamma were very reliable. If these tools were used in the field of clinical activity, the diagnosis of 
patients at risk of developing chronic periodontitis could be improved, leading to better, more cost-effective, 
methods of prevention and treatment of this disease.
On the other hand, Preshaw and Taylor, in an excellent review published in 201120, concluded that cytokines 
interact and function within networks, but we do not yet understand how the imbalance of the networks relates 
to the clinical course of periodontitis. In this regard, we are providing evidence through the development of 
cytokine-based predictive models and their corresponding nomograms. Interestingly, in the nomograms with 
more than one cytokine, unlike the position with IL1alpha, IL1beta, IL7A and smoking status, higher levels of 
IFNgamma and IL10 are associated with low scores. This reveals the level of the periodontitis-associated imbal-
ance between these pro-inflammatory (potentiating role) and these anti-inflammatory cytokines (protective role) 
in terms of a particular probability of having periodontitis.
Our research has some limitations. The most important weakness is that the prediction of the study’s accuracy 
is only measured in the samples that generated the model equations. As a consequence, to evaluate the reproduc-
ibility of the models, we validated the prediction rule internally (calibration, discrimination and classification 
measures) using bootstrap methods on the original derivation dataset by sampling with replacements for 1000 
iterations45, 64; the results in this respect were quite optimal. Another limitation was the sample size. Although we 
are in a scenario of small data, we believe that the concordance between the predictive results obtained and the 
biological knowledge of the subject indicate that we are on the right way.
The evaluation of these GCF cytokine-based predictive models and nomograms is a potential future research 
direction. Firstly, it would greatly benefit the strength of our study if the predictive accuracy of the models derived 
from our series could be measured in an “external” or independent cohort of patients to verify whether our find-
ings are universally applicable. Secondly, the potential prognostic value of these predictive models with regard to 
clinical progression of the disease and the response to treatment in periodontal patients should be exploited in 
longitudinal studies, as should their potential predictive accuracy in saliva samples.
In conclusion, of the 16 evaluated cytokines, the GCF levels of the eight pro-inflammatory (GMCSF, IL1alpha, 
IL1beta, IL6, IL12p40, IL17A, IL17F and TNFalpha) and four anti-inflammatory cytokines (IFNgamma, IL2, IL3 
and IL4) were significantly elevated in the patients with chronic periodontitis, with this increase in the concentra-
tions being stronger in the pro-inflammatory cytokines.
The outstanding predictive accuracy of the resulting smoking-adjusted models showed that IL1alpha, IL1beta 
and IL17A in GCF are very good biomarkers for distinguishing patients with chronic periodontitis from perio-
dontally healthy individuals. The predictive ability of these pro-inflammatory cytokines was increased by incor-
porating IFNgamma and IL10.
In the nomograms developed herein, higher levels of these pro-inflammatory cytokines and being a smoker 
increased the probability of having chronic periodontitis (potentiating role), while IFNgamma and IL10 had the 
opposite function (protective role). The clinical implications of these predictive tools could include improved 
patient monitoring and the control of disease activity. However, additional evidence is needed to test the external 
validity of these GCF cytokine-based models for predicting chronic periodontitis and their value for the clinical 
use of proposed nomograms.
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